Hepatitis C Virus Post-Exposure Prophylaxis for Health Care Workers

Summary

To assess the safety and tolerability of the use of telaprevir in the setting of post-exposure prophylaxis among HCW exposed to HCV genotype 1 or genotype 2. To assess the election rate of postexposure prophylaxis for HCV-related occupational exposures in HCW.

Timeline

Start

2013-04

Primary completion

2014-05

Completion

2014-05

Drugs

Indications